As per corporate shareholdings filed for Jun-2025, people matching Sands Capital Ventures, LLC publicly holds 19 stocks with a net worth of over US$ 516.0 M.
These are shares held by Sands Capital Ventures, LLC as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| Acumen Pharmaceuticals Inc | Sands Capital Ventures, Llc | 1.39 | 3,417,075 | 5.64% | 0.00 | 4.7 M | ||
| Acrivon Therapeutics Inc | Sands Capital Ventures, Llc | 1.36 | 2,122,605 | 6.75% | -0.02 | 2.9 M | ||
| Beta Bionics Inc. | Sands Capital Ventures, Llc | 18.97 | 3,570,113 | 8.21% | 1.07 | 67.7 M | ||
| BioAge Labs Inc. | Sands Capital Ventures, Llc | 4.74 | 786,353 | 2.19% | 0.00 | 3.7 M | ||
| Candel Therapeutics Inc | Sands Capital Ventures, Llc | 5.91 | 405,837 | 0.74% | -0.07 | 2.4 M | ||
| Coupang Inc - Ordinary Shares - Class A | Sands Capital Ventures, Llc | 28.24 | 849,031 | 0.05% | 0.00 | 24.0 M | ||
| Crowdstrike Holdings Inc - Ordinary Shares - Class A | Sands Capital Ventures, Llc | 422.61 | 15,615 | 0.01% | 0.00 | 6.6 M | ||
| DoorDash Inc - Ordinary Shares - Class A | Sands Capital Ventures, Llc | 245.65 | 381,202 | 0.09% | 0.00 | 93.6 M | ||
| Datadog Inc - Ordinary Shares - Class A | Sands Capital Ventures, Llc | 131.73 | 118,707 | 0.03% | 0.00 | 15.6 M | ||
| Inhibikase Therapeutics Inc | Sands Capital Ventures, Llc | 1.79 | 10,950,000 | 14.69% | -0.03 | 19.6 M | ||
| Samsara Inc - Ordinary Shares - Class A | Sands Capital Ventures, Llc | 35.65 | 438,485 | 0.08% | 0.03 | 15.6 M | ||
| Klaviyo Inc - Ordinary Shares - Series A | Sands Capital Ventures, Llc | 32.08 | 3,515,065 | 1.17% | 0.02 | 112.8 M | ||
| Monday.Com Ltd | Sands Capital Ventures, Llc | 181.80 | 58,336 | 0.11% | 0.02 | 10.6 M | ||
| Nu Holdings Ltd - Ordinary Shares Class A | Sands Capital Ventures, Llc | 14.64 | 7,175,434 | 0.15% | 0.00 | 105.0 M | ||
| Snowflake Inc - Ordinary Shares - Class A | Sands Capital Ventures, Llc | 200.39 | 27,005 | 0.01% | 0.00 | 5.4 M | ||
| Tarsus Pharmaceuticals Inc | Sands Capital Ventures, Llc | 57.82 | 170,000 | 0.40% | 0.00 | 9.8 M | ||
| Toast Inc - Ordinary Shares - Class A | Sands Capital Ventures, Llc | 43.86 | 156,604 | 0.03% | -0.01 | 6.9 M | ||
| Taysha Gene Therapies Inc | Sands Capital Ventures, Llc | 2.97 | 724,873 | 0.27% | 0.00 | 2.2 M | ||
| 10x Genomics Inc - Ordinary Shares - Class A | Sands Capital Ventures, Llc | 14.02 | 481,770 | 0.39% | 0.00 | 6.8 M | ||
| UiPath Inc - Ordinary Shares - Class A | 11.14 | - | Investor holds below 1% |